TAG:
executive war college
Are Live Lab Industry Conferences Returning?
By R. Lewis Dark | From the Volume XXVIII, No. 12 – September 7, 2021 Issue
For several months, many of you have used conversations and email to encourage us to conduct a live Executive War College before the end of 2021. It was because of this support that we arranged a hotel in a state that has supported a return to more normal activities. Thus, our conference will …
What Labs and Pathology Groups Can Expect in 2022
By R. Lewis Dark | From the Volume XXVIII, No. 11 – August 16, 2021 Issue
IN RECENT WEEKS, OUR EDITORIAL TEAM has been developing session topics and speakers for the upcoming Executive War College Presents: Preparing Your Clinical Laboratory and Pathology Group for Post-Pandemic Success, which happens on Nov. 2-3, 2021. It has been an eye-opening process because of …
Record 600 Pathologist Jobs Open Nationwide
By Robert Michel | From the Volume XXVIII, No. 11 – August 16, 2021 Issue
CEO SUMMARY: Demand for top-level pathologists is surging. A strong rise in the number of job openings for pathologists results from a combination of factors, some related to COVID-19. Now that physicians are seeing patients again, the number of specimens has risen after falling las…
Lab Briefs
By Robert Michel | From the Volume XXVIII, No. 7 – May 24, 2021 Issue
University of Miami Settles Lab Qui Tam Lawsuit for $22 Million EARLIER THIS MONTH, THE FEDERAL DEPARTMENT OF JUSTICE (DOJ) announced a settlement with the University of Miami that resolves allegations that the university ordered medicall…
Healthcare, Lab Market Trends Central Focus at Executive War College
By Kristen Noonan | From the Volume XXVII No. 4 – March 9, 2020 Issue
Powerful forces are at work transforming the U.S. healthcare system and the clinical laboratories that serve it. These forces will be identified and discussed at the upcoming 25th annual Executive War College…
January 27, 2020 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXVII No. 2 – January 27, 2020 Issue
In recent weeks, the Supreme Court declined to consider an appeal in a case which challenged a lab company’s patent on a clinical laboratory test. On Jan. 13, the justices rejected the appeal made by Athena Diagnostics, a division of Quest Diagnostics. In an earlie…
Health Insurers Spending Billions to Diversify
By R. Lewis Dark | From the Volume XXVI No. 15 – November 4, 2019 Issue
CEO SUMMARY: One big development affecting the health insurance business is how four of the nation’s largest health insurers are diversifying in significant ways. Last spring, a healthcare strategist explained how each of these companies has spent billions of dollars in recent years to …
Health Insurers Spending Billions to Diversify
By Joseph Burns | From the Volume XXVI No. 15 – November 4, 2019 Issue
CEO SUMMARY: One big development affecting the health insurance business is how four of the nation’s largest health insurers are diversifying in significant ways. Last spring, a healthcare strategist explained how each of these companies has spent billions of dollars in recent years to …
Strategist Explains Key Trends in Healthcare’s Transformation
By Joseph Burns | From the Volume XXVI No. 14 – October 14, 2019 Issue
CEO SUMMARY: Four trends are disrupting the nation’s healthcare system in ways that no one would have predicted just a few decades ago. Ted Schwab, a healthcare strategist, described these trends during his keynote presentation at the 24th Annual Executive War College in May. His insig…
Monitoring Patients on Opioids Is Opportunity for Clinical Labs
By Joseph Burns | From the Volume XXVI No. 13 – September 23, 2019 Issue
CEO SUMMARY: When developing a program to identify and treat patients who misused opioids or needed chronic opioid therapy, Community Health Network (CHN) of Indianapolis recognized that clinical lab toxicology tests were one of the few sources of objective data about patient compliance….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized